New approaches to the integrated management of early lung cancer

Hematology/Oncology Clinics of North America

Volumn 11, Issue 2, 1997, Pages 235-252

  Mulshine, J L ^a   Zhou, J ^a   Treston, A M ^a   Szabo, E ^a   Tockman, M S ^a   Cuttitta, F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; DOCEBENONE; GASTRIN RELEASING PEPTIDE; GROWTH FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HORMONE ANTAGONIST; LIPOXYGENASE INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 703D4; NORDIHYDROGUAIARETIC ACID; ONCOPROTEIN; PROTEIN P53; RETINOID; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG;

AUTOMATION; CANCER DIAGNOSIS; CANCER SCREENING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; EARLY CANCER; EARLY DIAGNOSIS; GENE MUTATION; HIGH RISK POPULATION; HUMAN; IMMUNOCYTOCHEMISTRY; INHALATIONAL DRUG ADMINISTRATION; LUNG CANCER; MEDICAL TECHNOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SPUTUM CYTODIAGNOSIS;

EID: 0030900587     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70428-7     Document Type: Article

References (101)

1. S.M. Aguayo Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers J Clin Invest 84 1989 1105
2. B.N. Ames The causes and prevention of cancer Proc Natl Acad Sci USA 92 1995 5258
3. O. Auerbach Changes in the bronchial epithelium in relation to smoking and cancer of the lung N Engl J Med 256 1957 97
4. I. Avis Preclinical evaluation of an anti–growth factor monoclonal antibody to treat patients with lung cancer J Natl Cancer Inst 83 1991 1470
5. I. Avis Analysis of small cell lung cancer growth inhibition by 13-cis-retinoic acid: Importance of bioavailability Cell Growth Differ 6 1995 485
6. I. Avis Growth control of lung cancer by interruption of the 5-lipoxygenase–mediated growth factor signaling J Clin Invest 97 1996 806
7. J.C. Bailar Early lung cancer cooperative study group: Early lung cancer detection. Summary and conclusion Am Rev Respir Dis 130 1984 565
8. J.C. Bailar Editorial: Screening for lung cancer—where are we now? Am Rev Respir Dis 130 1984 541
9. F. Barany Genetic disease detection and DNA amplification using cloned thermostable ligase Proc Natl Acad Sci USA 88 1991 189
10. R. Baserga Oncogene and the strategy of growth factors Cell 79 1994 927
11. T. Beardsley The war not won Sci Am 1 1994 130
12. T. Beardsley Better than a cure Sci Am 1 1995 88
13. S.E. Benner Prevention of second primary tumors with isotretinoin in patients with squamous carcinoma of the head and neck: Long-term follow-up J Natl Cancer Inst 86 1994 140
14. W.P. Bennett p53 protein accumulates frequently in early bronchial neoplasia Cancer Res 53 1993 4817
15. K.R. Boucot W. Weiss Is curable lung cancer detected by semiannual screening? JAMA 224 1973 1361
16. T.A. Brentnall Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis Cancer Res 55 1995 4264
17. G.Z. Brett Earlier Diagnosis and Survival in Lung Cancer Br Med J 4 1969 260
18. F.S. Collins BRCA1—lots of mutations, lots of dilemmas N Engl J Med 334 1996 186
19. F. Cuttitta Bombesin like peptides can function as autocrine growth factors in human small cell lung cancer Nature 316 1985 823
20. V.T. DeVita Combination versus single agent chemotherapy: Review of basis for selection of drug treatment of cancer Cancer 35 1975 98
21. M. Eggers A microchip for quantitative detection of molecules utilizing luminescent and radioisotope reporter groups Biotechniques 17 1994 516
22. Z. Fathi Bombesin receptor structure and expression in human lung carcinoma cell lines J Cell Biochem Suppl 24 1996 237
23. R.E. Finney J.M. Bishop Predisposition to neoplastic transformation caused by gene replacement of H-ras1 Science 260 1993 1524
24. R.S. Fontana Early lung cancer detection: Results from the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study Am Rev Respir Dis 130 1984 561
25. J.K. Frost Early lung cancer detection: Summary and conclusions Am Rev Respir Dis 130 1984 565
26. J.K. Frost Early lung cancer detection: Results from the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study Am Rev Respir Dis 130 1984 549
27. M. Gaffney B. Altshuler Examination of the role of cigarette smoke in lung carcinogenesis J Natl Cancer Inst 80 1988 925
28. F.L. Grover S. Piantadosi Recurrence and survival following resection of bronchiolar carcinoma of the lung—the Lung Cancer Study Group experience Ann Surg 209 1990 779
29. P.H. Gumerlock Activated ras alleles in human carcinoma of the prostate are rare Cancer Res 51 1991 1632
30. C.C. Harris M. Hollstein Clinical implications of the p53 tumor-suppressor gene N Engl J Med 329 1993 1318
31. W.K. Hong Prevention of second primary tumors in squamous cell carcinoma of the head and neck with 13-cis-retinoic acid N Engl J Med 323 1990 795
32. D.R. Jacobson N.E. Mills A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia Oncogene 9 1994 553
33. P. Johnstone I. McConnan Primary health care led NHS: Learning from developing countries Br Med J 311 1995 891
34. R. Jones The impact of molecular medicine on health services Nature Med 2 1996 959
35. G.J. Kelloff C.W. Boone Cancer chemopreventive agents: Drug development status and future J Cell Biochem Suppl 1995 221
36. A. Kubik Lack of benefit from semi-annual screening for cancer of the lung: Follow up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia Int J Cancer 45 1990 26
37. R. Kumar L.L. Dunn Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes Oncogene Research 1 1989 235
38. A.A. Langston BRCA1 mutations in a population-based sample of young women with breast cancer N Engl J Med 334 1996 137
39. T.A. Lehman Detection of K-ras oncogene mutations by polymerase chain reaction–based ligase chain reaction Anal Biochem 239 1996 153
40. Z.H. Li c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung Am J Pathol 144 1994 303
41. P. Liang A.B. Pardee Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction Science 257 1992 967
42. A. Lilienfeld An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A cooperative pilot study of the American Cancer Study and the Veterans Administration Can Res 26 1966 2083
43. R.I. Linnoila S.C. Aisner Pathology of lung cancer: An exercise in classification Johnson B.E. Johnson D.H. Lung Cancer 1995 Wiley-Liss New York 73 95
44. S. Lippman S. Benner W. Hong Cancer chemoprevention J Clin Oncol 12 1994 851
45. L. Mao Detection of oncogene mutation in sputum precedes the diagnosis of lung cancer Cancer Res 54 1994 1634
46. L. Mao Microsatellite alterations as clonal markers in the detection of human cancer Proc Natl Acad Sci USA 91 1994 9871
47. M.R. Melamed Screening for early lung cancer. Results from the Memorial Sloan-Kettering Study in New York Chest 88 1984 44
48. N.E. Mills Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis J Natl Cancer Inst 87 1995 1056
49. N.E. Mills Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma Cancer Res 55 1995 1444
50. P.J. Morin B. Vogelstein K.W. Kinzler Apoptosis and APC in colorectal tumorigenesis Proc Natl Acad Sci USA 93 1996 7950
51. J.L. Mulshine F. Scott Molecular markers in early cancer detection. New screening tools Chest 107 suppl 1995 280S
52. J.L. Mulshine Applications of monoclonal antibodies in the treatment of solid tumors DeVita V. Hellman S. Rosenberg S. Biologic Therapy of Cancer 1991 563
53. J.L. Mulshine Applications of biomarkers for lung cancer early detection Fortner J. Rhoads J. Accomplishments in Cancer Research 1993 JB Lippincott Philadelphia 203
54. J.L. Mulshine The correct dose: Pharmacologically guided end point for anti–growth factor therapy Cancer Res 52 suppl 1992 2743S
55. J.L. Mulshine M.S. Tockman C.R. Smart Consideration in the development of lung cancer screening tools J Natl Cancer Inst 81 1989 900
56. J.L. Mulshine New approach to the management of lung cancer: Rational strategies for early detection and intervention Oncology 5 1990 25
57. Y. Nakanishi Small cell lung cancer cells autostimulate their growth via an insulin-like growth factor-I activity: Evaluation of 4 cell lines J Clin Invest 82 1988 354
58. F.A. Nash J.M. Morgan J.G. Tomkins South London cancer study Br Med J 2 1968 715
59. G.N. Papanicolaou Diagnostic value of exfoliated cells from cancerous tissue JAMA 131 1946 372
60. G.N. Papanicolaou H.F. Traut The diagnostic value of vaginal smears in carcinoma of the uterus Am J Obstet Gynecol 42 1941 193
61. L.F. Parada Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation Nature (Lond) 312 1984 649
62. S.L. Parker Cancer statistics, 1996 CA Cancer J Clin 65 1996 5 27
63. Patton JS: Mechanisms of macromolecule absorption by the lung. Journal of Advanced Drug Delivery Rev, in press
64. R. Peto Mortality from tobacco in developed countries: Indirect estimation from national vital statistics Lancet 339 1992 1268
65. S. Piantadosi Long term follow-up of surgically resected T1N0 non–small cell lung cancer Lung Cancer 4 suppl 1988 82
66. K.A. Quinn Insulin-like growth factor expression in human lung and breast cancer cell lines J Biol Chem 271 1996 11477
67. M. Resnicoff Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptor Cancer Res 55 1995 3739
68. G. Saccomanno V.E. Archer O. Auerbach Development of carcinoma of the lung or reflected in exfoliated cells Cancer 33 1974 256
69. F.M. Schabel Rationale for adjuvant chemotherapy Cancer 36 1977 2875
70. C.J. Schilling J.M. Schilling Chest x-ray screening for lung cancer at three British chromate plants from 1955 to 1989 Br J Indust Med 48 1991 476
71. F. Scott Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage J Cell Biochem Suppl 17F 1993 175
72. F. Scott Early lung cancer detection using monoclonal antibodies Roth J.A. Cox J.D. Hong W.K. Lung Cancer 1993 Blackwell Scientific London 310
73. F.M. Scott Peptide amidating activity in human bronchoalveolar lavage fluid as a potential neuroendocrine marker for early lung cancer detection Lung Cancer 14 1996 239
74. F. Scott High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluids of patients at high risk for second primary lung cancer Proc Am Assoc Cancer Res 37 1996 101
75. D. Sidransky Molecular screening—how long can we afford to wait? J Natl Cancer Inst 87 1994 955
76. D.P. Slaughter H.W. Southwick W. Smejkal “Field cancerization” in oral stratified squamous epithelium Cancer 6 1953 963
77. R.J. Slebos S. Rodenhuis The ras gene family in human non–small-cell lung cancer Mongr Natl Cancer Inst 13 1992 23
78. C.E.H. Steward P. Rotwein Insulin-like growth factor II is an autocrine survival factor for differentiating myoblasts J Biol Chem 271 1996 11330
79. K. Sugio K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas Cancer Res 54 1994 5811
80. M.E. Sunday Bombesin increases fetal lung growth and maturation in utero and in organ cultures Am J Respir Cell Mol Biol 3 1990 199
81. Lung cancer prevention: Historical and future perspectives
82. C. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456
83. M. Tobi F.C. Luo Z. Ronai Detection of K-ras mutations in colonic effluent samples from patients without evidence of colorectal carcinoma J Natl Cancer Inst 86 1994 1007
84. M.S. Tockman Screening for adult respiratory disease: The official ATS statement Am Rev Respir Dis 128 1983 768
85. M.S. Tockman Screening and detection of lung cancer Aisner J. Lung Cancer 1985 Churchill Livingstone New York 25
86. M.S. Tockman Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: A new approach to early lung cancer detection J Clin Oncol 6 1988 1685
87. M.S. Tockman Cytometric validation of immunocytochemical observations in developing lung cancer Diagnostic Cytopathology 9 1994 615
88. M.S. Tockman An approach to clinical application of a lung cancer biomarker Srivastava S. Lippman S. Hong W.K. Mulshine J.L. Early Detection of Cancer: Challenge of Molecular Biology 1994 Futura Armonk, NY 167
89. M.S. Tockman The early detection of second primary lung cancers by sputum immunostaining. LCEDWG investigators. Lung cancer early detection working group Chest 106 suppl 1994 385S
90. H. Veeken Cuba: Plenty of care, few condoms, no corruption Br Med J 311 1995 935
91. W. Weiss The Philadelphia Pulmonary Neoplasm Research Project Am Rev Respir Dis 111 1975 M289
92. W.H. Westra K-ras oncogene activation in atypical alveolar hyperplasias of the human lung Cancer Res 56 1996 2224
93. E. White Life, death and the pursuit of apoptosis Genes Dev 10 1996 1
94. M. Wiedmann Ligase chain reaction (LCR)—overview and applications PCR Methods and Applications 3 1994 S51
95. J. Wilde A 10-year follow up of semi-annual screening for lung cancer in Erfurt County, GDR Eur Respir J 2 1989 656
96. J.C. Willey J.R. Lechner C.C. Harris Bombesin and the C-terminal tetradecapeptides of gastrin-releasing peptides are growth factors for normal human bronchial epithelial cells Exp Cell Res 153 1984 245
97. S.H. Woolf Screening for prostate cancer with prostate-specific antigen N Engl J Med 333 1995 1401
98. M.S. Yakubovskaya High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer Int J Cancer 63 1995 810
99. G. Yershov DNA analysis and diagnostics on oligonucleotide microchips Proc Natl Acad Sci USA 93 1996 4913
100. J. Zhou Purification and characterization of a protein which permits early detection of lung cancer: Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody, 703D4 J Biol Chem 271 1996 10760
101. J. Zhou Expression of early lung cancer detection marker P31 in neoplastic and non-neoplastic respiratory epithelium Lung Cancer 14 1996 85